Emirates Drug Establishment approves world's first oral therapy for immune thrombocytopenia
With this landmark approval, the UAE becomes the first country in the world to authorise this innovative medication, reflecting the nation's global leadership in accelerating access to advanced treatments and addressing critical medical needs.
The approval of Rilzabrutinib in the UAE represents a major step forward, offering patients with ITP early access to a pioneering therapeutic solution that contributes to a faster treatment journey and a tangible improvement in quality of life.
The decision aligns with the UAE's strategic commitment to ensuring the availability of high-efficacy, globally benchmarked treatments in line with the highest international standards and protocols.
Developed by global pharmaceutical and healthcare company Sanofi, Rilzabrutinib represents a breakthrough in restoring immune system balance by targeting the underlying cause of ITP.
By increasing platelet counts, the treatment addresses both the symptoms and root causes of the condition. Clinical studies have demonstrated promising outcomes, with patients reporting substantial improvement in health indicators.
Dr. Fatima Al Kaabi, Director-General of the Emirates Drug Establishment, stated, 'The UAE is committed to providing access to the world's latest therapeutic innovations and further promoting its position as a regional hub for pharmaceutical excellence. With Rilzabrutinib getting approved, we take another step further in achieving our strategy aimed at enhancing national pharmaceutical security, implementing advanced treatment protocols, and streamlining regulatory frameworks in collaboration with international partners.'
Dr. Al Kaabi emphasised that the milestone demonstrates the effectiveness of the UAE's proactive healthcare policies and flexible regulatory systems in fostering innovation and facilitating patient access to advanced medications.
'The Emirates Drug Establishment will spare no effort to accelerate regulatory procedures, and strengthen global partnerships,' she said. 'This further solidifies the UAE's role as a regional centre for pharmaceutical innovation.'
She added, 'Granting approval for Rilzabrutinib reaffirms the Establishment's commitment to fast-tracking access to transformative therapies that create significant impact, particularly in the treatment of rare and chronic diseases. EDE will continue to adopt a proactive, innovation-driven approach, fuelled by international collaboration, to ensure that safe, effective therapeutic options are available across the country in accordance with the highest global standards. Our goal is to enhance the UAE's health system preparedness in an era of rapid scientific progress.'
For her part, Preeti Futnani, MCO Lead and General Manager, Specialty Care for KSA & Gulf Countries at Sanofi, said, 'We are honoured to collaborate with the Emirates Drug Establishment to bring this groundbreaking treatment to patients in the UAE living with Immune Thrombocytopenia. The approval of Rilzabrutinib demonstrates our shared commitment to placing patients at the centre of our mission and delivering cutting-edge solutions that address some of the most pressing unmet medical needs.'
Follow Emirates 24|7 on Google News.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
3 hours ago
- Khaleej Times
From Ozempic to Mounjaro: Why Dubai restaurants are rethinking portion sizes
With skinny jabs and shrinking waistlines becoming the new normal, many fitness conscious are opting for smaller, selective palate. As a result, the food industry is looking for ways to reimagine the culinary scene. Banc, Downtown Dubai's newest hotspot, has just launched a brand-new menu for reduced appetites due to weightloss injections like Ozempic, Mounjaro and Wegovy. Ever since the news went out, it's generated a lot of interest. Everyone's calling it the 'Ozempic menu.' Banc's founders give us the lowdown on the facts, benefits and potential flipside of this trend. 'Let's clear one thing up right away — this isn't an 'Ozempic menu'. We're not doctors, and we're certainly not here to prescribe trends. But what we are seeing, both in London and now in Dubai, is a change in how people are eating. Appetite-suppressing medications like GLP-1s — which are prescribed by professionals for specific medical reasons — have a clear side effect: people just aren't eating as much. We were getting more and more guests asking, 'Can I get a smaller portion of this?' Some would share a main or skip dessert entirely. And we thought, why not meet people halfway? So we created The Mini Bancer – a menu featuring smaller portions of our most-popular dishes and drinks. It's all about flavour, just in less volume,' starts off Mazlum Topcu, co-founder of The Banc, located in Dubai and London. The founders noticed that in London, the guests still wanted the experience of dining out, but they were choosing differently. Hence, the idea of a 'skinny jab menu'. 'The average spending per head dipped, and that has a direct impact on the bottomline. But rather than fight it, we decided to get creative – without compromising on quality or creativity. Rather than a full three-course meal, they will order a few lighter plates,' says co-founder Can Topcu. The Mini Bancer menu is not just for people on GLP-1s (Type 2 diabetics); Banc is looking at a wider audience. 'We're seeing athletes, professionals, even foodies who just want to enjoy greater variety without feeling stuffed. It's also great for people with lighter appetites – or those trying to make more mindful choices without missing out on the pleasure of dining out,' explains Mazlum. The 'skinny jab menu' is for those with smaller appetites but still want to dine out and eat good food. Can Topcu adds, 'And let's be honest, Dubai is a city that loves a good night out, but it also cares deeply about health and image. This kind of menu fits naturally into that lifestyle. It's not about diet culture. It's about choice, balance, and still indulging in your favourite dishes – just in a way that suits how you're feeling that day. Guests don't want to feel left out or embarrassed by leaving half their meal or telling the table they are not drinking because they are on medication, have an early morning workout, or have other commitments.' By catering to GLP-1 users and health-conscious diners, Banc's 'inclusive' menu could be a game-changer. But what are the potential advantages and disadvantages of the 'Ozempic menu'? Will some diners feel self-conscious about ordering from a menu specifically designed for those on weight-loss medications? 'We see this as a new era for hospitality. It challenges us to think beyond 'bigger is better'. A miniature beverage or baklava bite dessert, they still use the same premium ingredients and techniques — it's not a shortcut – and the price reflects the smaller size. It's thoughtful, it's elegant, and frankly, it's a lot more fun than just saying 'no' to dessert,' says Mazlum. 'The upside is simple: it's inclusive. Whether you're on a medical programme, watching your portion sizes, or cutting back on drinking, this menu gives people the option to dine how they want. It's respectful of changing appetites, changing drinking habits, and a broader wellness mindset,' adds Can. The founders also believe that serving smaller portions could reduce food waste, aligning with sustainable dining practices. 'It's taken some adjusting. Smaller serves mean we've had to be smarter with curation, but the result is still high-impact and high-value. Sure, a few have called it a gimmick, but you can't please everyone. Introducing something new is always a gamble, but responding to guest feedback isn't trend-chasing – it's just good hospitality,' he says. After doing a trial run at their London location, the concept has made its UAE debut this month, blending The Banc's signature Mediterranean flavours with a narrower, health-conscious approach to dining. Terming their new menu as 'The Mini Bancer', this is a thoughtfully designed section of the menu, offering lighter, more intentional versions of the restaurant's most popular dishes and beverages. 'I think we're just trying to be honest with where people are right now. The way people eat is changing. Their habits, their appetites, their beverage choices – all of it. And as restaurateurs, we either adapt or get left behind. This isn't about Ozempic. It's about flexibility. Hospitality should never be one-size-fits-all,' explains Mazlum. Banc plans to tap into the UAE's growing market of health-conscious foodies who want nutritious and tasty options. 'We're deeply invested in Dubai, but the UAE has so many exciting markets. The feedback here has been incredible, and we're exploring opportunities to grow organically, without losing what makes The Banc special,' Can concludes.
Khaleej Times
7 hours ago
- Khaleej Times
UAE: For heart attack recovery, check for anxiety, depression symptoms, say doctors
When someone survives a heart attack, the immediate focus tends to be on the physical crisis, the blocked artery, the stent, and the electrocardiogram (ECG). But experts say it's not just about the artery; it's about more than heart health. Recovery extends beyond repairing the heart muscle. It often involves navigating a wave of emotional aftershocks: fear, anxiety, vulnerability, and sometimes a profound identity crisis. Doctors emphasize that healing is not a linear path — it's a complex and ongoing journey that affects the mind, emotions, and relationships. Empathy helps healing 'Healing the heart involves far more than restoring blood flow. It also means helping patients deal with fear, anxiety, and often a profound sense of vulnerability,' said Dr Shady Habboush, Consultant Interventional Cardiologist at Saudi German Hospital, Dubai. Dr Habboush believes that effective healing starts with listening. Many patients don't volunteer that they feel anxious or depressed — unless someone asks. 'Simple screening tools like the PHQ‑2 for depression or GAD‑7 for anxiety during follow-up visits or cardiac rehab can be used. But beyond the forms, paying attention to what they're not saying — silence, hesitation, or the subtle shift in tone when they talk about the future — these are all emotional red flags," Dr Habboush said. A team effort toward recovery Emotional support plays a critical role in the healing process. Dr Habboush encourages involving family members as much as possible — both for educational purposes and for day-to-day motivation. 'A supportive spouse, a caring son or daughter — these people are often the ones making meals, managing medications, or encouraging walks when motivation is low," he said. Experts advised not to wait until signs of more profound emotional distress emerge. 'It's recommended that doctors refer patients to mental health professionals or cardiac support groups. Suppose they see signs of clinical depression, anxiety, or fear of recurrence. In that case, it's better not to hesitate to involve a psychologist,' he added. The invisible wound Dr Rahul Chaudhary, Interventional Cardiologist and Head of Department at International Modern Hospital Dubai, speaks of what he calls 'the invisible wound'. 'There's the anxiety that lingers long after the ECG normalizes. Some patients avoid physical activity entirely, fearing it might 'trigger' another attack. Others downplay their condition and resist follow-up, as if acknowledging the disease gives it power," Dr Chaudhary said. He explained that patients who were previously healthy and active may struggle to come to terms with their new reality. 'Suddenly, they go from being a provider, a leader, or an active individual to someone who feels fragile and uncertain.' For these individuals, lifestyle changes can feel overwhelming. 'One-size-fits-all advice rarely works. We have to acknowledge that lifestyle changes after a heart attack aren't minor tweaks — they are, for many, a full paradigm shift. People are often overwhelmed because they're given a list: stop smoking, walk more, take five medications, avoid stress, eat differently — all while processing a life-threatening event," he said. Essentials of recovery Dr Srinivasan Kandasamy, Specialist Cardiologist at Aster Hospital Qusais, outlines the core changes that must be made in the aftermath of a heart attack. 'Following a heart attack, the most critical lifestyle changes include quitting smoking, adopting a heart-healthy diet, engaging in regular physical activity, and maintaining a healthy weight — all while adhering strictly to prescribed medications.' He advised that most patients should avoid strenuous activity for four to six weeks. However, many can resume their regular daily routines within one to two weeks, depending on their recovery. When it comes to diet and exercise, he recommends a balanced, sustainable approach: "Diet recommendations focus on whole grains, lean proteins, healthy fats such as those found in nuts and PUFA oils, and minimizing sugary foods and beverages. Regular aerobic exercise — like brisk walking for 30 to 40 minutes, three to four times a week — is encouraged.' For smoking cessation, Dr Kandasamy emphasizes behavioural strategies, medication when needed, and identifying personal triggers. Long-term adherence, he says, depends on consistency, education, and support. 'Cardiac rehabilitation programs help assess and individualize a patient's functional capacity. They enhance cardiovascular fitness, provide psychological support, and help modify cardiac risk factors. While not mandatory for all, these programmes are highly recommended for most patients," he said.
Khaleej Times
8 hours ago
- Khaleej Times
Advancing the future of healthcare in UAE: Kings unveils breakthrough gastric pacemaker technology
In a major leap forward for digestive health in the region, King's College Hospital Dubai has become amongst the first hospitals in the UAE to introduce the gastric pacemaker, a pioneering treatment designed for patients suffering from severe gastroparesis. Often misunderstood and notoriously difficult to treat, gastroparesis affects the stomach's ability to empty properly, causing chronic nausea, pain, bloating, and complications that can seriously impact day-to-day life. While the condition is known to be complex, what makes King's approach unique is not just the technology, but the breadth of care surrounding it. The hospital is now home to the UAE's only truly comprehensive gastroparesis service, one of the only places in the country where patients can access a full multidisciplinary team (MDT) specialising in the condition. This includes gastroenterologists, surgeons, psychiatrists, pain specialists, psychologists, endocrinologists, neuromuscular specialists, and neurologists working together under one roof. 'Gastroparesis can't be solved with a one-size-fits-all solution,' said Dr Farooq Khan, consultant hepatologist, gastroenterologist and interventional endoscopist. 'It requires a deep understanding of the condition from every angle like medical, psychological, and lifestyle related. That's what we've built here.' The centre also leads the way in advanced interventions. King's is the only facility in the UAE offering gastric pacemaker implantation, a device that stimulates the stomach muscles to help restore natural movement and function. In addition, patients have access to cutting-edge endoscopic therapies that are often less invasive than traditional surgery and tailored to individual cases. But perhaps most importantly, the philosophy at King's is to treat the whole patient, not just the symptoms. Many individuals with gastroparesis have underlying or contributing conditions such as diabetes or neurological disorders, and treatment is designed with this full picture in mind. 'We're not here to simply manage pain or prescribe anti-nausea medication,' said Dr Bratislav Spica, specialist general surgeon. 'We're here to give patients back the quality of life they may have lost; using tools, technologies, and expertise you simply can't find anywhere else in the country.' With its blend of medical innovation and collaborative care, King's College Hospital Dubai has positioned itself as the national leader in gastroparesis treatment and a vital resource for patients across the UAE seeking answers, support, and a path forward.
